The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction
- PMID: 15034
The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction
Abstract
The allogeneic effect has been employed as a potent immunopotentiator in preventing the growth of a murine plasmacytoma and prolonging host survival. Parental BALB/c spleen cells were passively transferred to (BALB/c x A/H)F1 hybrid mice, who were then given a highly lethal dose of MOPC 315 plasmacytoma, a tumor of BALB/c origin. The resultant graft-vs-host reaction protected the recipient mice against growth of the tumor and significantly prolonged survival. This phenomenon was dependent upon the dose of BALB/c lymphoid cells employed, the route of administration, and the time interval between lymphoid cell transfer and tumor inoculation. A wide range of lymphoid cell doses and time intervals were effective, and repeated doses of allogeneic cells provided better protection than a single dose.
Similar articles
-
The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.J Immunol. 1977 Apr;118(4):1449-55. J Immunol. 1977. PMID: 15035
-
Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.J Natl Cancer Inst. 1982 Jun;68(6):963-9. J Natl Cancer Inst. 1982. PMID: 6953275
-
Protection against MOPC-315 plasmacytoma by immunization with C-type particle preparations.Cancer Res. 1978 Jan;38(1):223-5. Cancer Res. 1978. PMID: 201375
-
An experimental model for evaluation of factors in tumor escape from immunological attack.Cancer Res. 1975 Mar;35(3):734-9. Cancer Res. 1975. PMID: 1116132
-
[Effect of the graft vs. host reaction on the take and growth of normal and tumorous tissues].Patol Fiziol Eksp Ter. 1973 Jan-Feb;17(1):77-81. Patol Fiziol Eksp Ter. 1973. PMID: 4149834 Review. Russian. No abstract available.
Cited by
-
The presence of a tumour in F1 mice partially inhibits the GvH reaction following injection of parental spleen cells.Br J Cancer. 1981 Mar;43(3):305-11. doi: 10.1038/bjc.1981.48. Br J Cancer. 1981. PMID: 7225282 Free PMC article.
-
Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.Cancer Immunol Immunother. 1983;15(2):101-7. doi: 10.1007/BF00199699. Cancer Immunol Immunother. 1983. PMID: 6553510 Free PMC article.
-
Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.Immunology. 1980 May;40(1):67-76. Immunology. 1980. PMID: 7419243 Free PMC article.